These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37000124)

  • 1. Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    Baringer SL; Simpson IA; Connor JR
    J Neurochem; 2023 Jun; 165(5):625-642. PubMed ID: 37000124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of altered brain iron acquisition in restless legs syndrome.
    Connor JR; Ponnuru P; Wang XS; Patton SM; Allen RP; Earley CJ
    Brain; 2011 Apr; 134(Pt 4):959-68. PubMed ID: 21398376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19.
    Naidu SAG; Wallace TC; Davies KJA; Naidu AS
    J Diet Suppl; 2023; 20(2):218-253. PubMed ID: 33977807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    Bailey DK; Clark W; Kosman DJ
    PLoS One; 2021; 16(7):e0254794. PubMed ID: 34310628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain iron metabolism and its perturbation in neurological diseases.
    Crichton RR; Dexter DT; Ward RJ
    J Neural Transm (Vienna); 2011 Mar; 118(3):301-14. PubMed ID: 20809066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron uptake at the blood-brain barrier is influenced by sex and genotype.
    Wade QW; Chiou B; Connor JR
    Adv Pharmacol; 2019; 84():123-145. PubMed ID: 31229168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cells are critical regulators of iron transport in a model of the human blood-brain barrier.
    Chiou B; Neal EH; Bowman AB; Lippmann ES; Simpson IA; Connor JR
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2117-2131. PubMed ID: 29911470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel model for brain iron uptake: introducing the concept of regulation.
    Simpson IA; Ponnuru P; Klinger ME; Myers RL; Devraj K; Coe CL; Lubach GR; Carruthers A; Connor JR
    J Cereb Blood Flow Metab; 2015 Jan; 35(1):48-57. PubMed ID: 25315861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
    Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
    J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.
    Rios Romenets S; Dauvilliers Y; Cochen De Cock V; Carlander B; Bayard S; Galatas C; Wolfson C; Postuma RB
    Parkinsonism Relat Disord; 2013 Jan; 19(1):92-4. PubMed ID: 22922159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy.
    Connor JR; Duck K; Patton S; Simpson IA; Trotti LM; Allen R; Earley CJ; Rye D
    Fluids Barriers CNS; 2020 Apr; 17(1):28. PubMed ID: 32295615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases.
    Campos-Escamilla C
    Adv Protein Chem Struct Biol; 2021; 123():133-162. PubMed ID: 33485481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired iron homeostasis in Parkinson's disease.
    Double KL; Gerlach M; Youdim MB; Riederer P
    J Neural Transm Suppl; 2000; (60):37-58. PubMed ID: 11205155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain iron transport.
    Qian ZM; Ke Y
    Biol Rev Camb Philos Soc; 2019 Oct; 94(5):1672-1684. PubMed ID: 31190441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na
    Beydoun R; Hamood MA; Gomez Zubieta DM; Kondapalli KC
    J Biol Chem; 2017 Mar; 292(10):4293-4301. PubMed ID: 28130443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β exposed astrocytes induce iron transport from endothelial cells at the blood-brain barrier by altering the ratio of apo- and holo-transferrin.
    Baringer SL; Lukacher AS; Palsa K; Kim H; Lippmann ES; Spiegelman VS; Simpson IA; Connor JR
    bioRxiv; 2023 May; ():. PubMed ID: 37292926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.